Track: Paediatric Neurology

Neuropsychiatry 2025

The "Paediatric Neurology" track focuses on the study, diagnosis, and management of neurological disorders in infants, children, and adolescents. This session delves into a broad spectrum of conditions, from developmental disorders to complex neurological diseases, with a strong emphasis on cutting-edge research, innovative treatments, and family-centered care. Participants will gain insights into advancements in neurogenetics, neuroimaging, and therapeutic approaches that are shaping the future of pediatric neurological care.

Developmental and Neurogenetic Disorders:
This session examines conditions like cerebral palsy, intellectual disabilities, and neurogenetic syndromes, such as Rett syndrome and fragile X syndrome. Discussions will include the role of genetic testing, early intervention strategies, and emerging therapies that address developmental challenges in pediatric patients.

Pediatric Epilepsy and Seizure Disorders:
This topic explores the latest advances in the diagnosis and management of epilepsy in children. Attendees will learn about innovative antiepileptic drugs, surgical interventions, ketogenic diets, and novel neuromodulation techniques, as well as strategies for addressing the psychosocial impacts of epilepsy on children and families.

Neuromuscular Disorders in Children:
This session focuses on conditions such as Duchenne muscular dystrophy and spinal muscular atrophy. Topics will include gene therapy advancements, emerging pharmacological treatments, and the importance of multidisciplinary care in optimizing quality of life and functional outcomes.

Neuroinflammatory and Autoimmune Disorders:
This segment explores pediatric conditions like multiple sclerosis, acute disseminated encephalomyelitis (ADEM), and autoimmune encephalitis. Participants will gain insights into early diagnosis, immunomodulatory treatments, and long-term management strategies for these complex disorders.

Pediatric Neuro-Oncology:
This session highlights the challenges and advancements in diagnosing and treating pediatric brain and spinal tumors. Discussions will include novel surgical techniques, targeted therapies, and supportive care strategies aimed at improving survival rates and quality of life for affected children.

Neonatal Neurology:
The neurological conditions in newborns, such as hypoxic-ischemic encephalopathy, neonatal seizures, and neurodevelopmental outcomes in preterm infants. Attendees will learn about advancements in neuroprotective therapies, including therapeutic hypothermia, and approaches to optimize long-term developmental outcomes.

Behavioral and Psychiatric Neurology in Children:
This session explores the intersection of neurology and psychiatry in pediatric patients, focusing on conditions like ADHD, autism spectrum disorder (ASD), and Tourette syndrome. Discussions will include the latest research on neurobiological underpinnings, diagnostic criteria, and multimodal treatment approaches.

Innovations in Pediatric Neuroimaging:
This segment highlights advancements in neuroimaging techniques, such as functional MRI, diffusion tensor imaging, and PET scans, and their role in diagnosing and managing pediatric neurological disorders. Discussions will also touch on the ethical considerations of imaging in children.

This track offers a comprehensive understanding of pediatric neurological disorders, providing attendees with practical knowledge and research-based insights to improve clinical practice and outcomes for young patients and their families.